Covid-19 vaccine 90% effective in phase 3 trial: Pfizer

New Delhi, Nov 09: A vaccine jointly developed by American pharmaceutical giant Pfizer along with German biotech company BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials.   "The first set of results from our

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/32u4hTu

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post